Immunotherapy and Pancreatic Cancer: Hope for the Future?
The MUC1 immunotherapeutic target may help to enhance the body’s natural response to cancer cells, thereby extending pancreatic cancer survival.
Diagnosis & Disease Information
Celgene Announces Abraxane (Paclitaxel Injection) Plus Gemcitabine Prolongs Overall Survival in Metastatic Pancreatic Cancer
Abraxane (paclitaxel injection) plus gemcitabine is associated with prolonged survival among patients with metastatic pancreatic cancer.
Genome Analysis Reveals Mutations Underlying Pancreatic Cancer
Important research from the International Cancer Genome Consortium has identified thousands of genetic mutations associated with pancreatic cancer.
ACG: Pancreatic Adenocarcinoma is More Aggressive in Absence of Intraepithelial PanIn Dysplasia
Pancreatic adenocarcinoma found in the absence of pancreated intraepithelial neoplasia is more aggressive and associated with poorer prognosis than tumors found in the presence of PanIN.
KRAS Mutation Subtypes Associated with Different Survival Times in Pancreatic Cancer
Specific KRAS mutation subtypes are associated with poorer overall survival times among patients with unresectable pancreatic cancer.
Gemcitabine-based Combination Therapy for Advanced Pancreatic Cancer: Modestly Superior OS but Worse Toxicities
Gemcitabine-based combination therapies for patients with advanced pancreatic cancer offer modestly but statistically-significantly improved overall survival but increased toxicities.
EGFR Signaling Mediates KRAS Involvement in Mouse Models of Pancreatic Carcinogenesis
EGFR signaling plays a key role in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma tumorigenesis and progression, suggesting a new potential therapeutic target.
Study Data May Improve Quality of Life in Pancreatic Cancer Patients
Hospitalization data will help patients with pancreatic cancer to make more informed choices regarding their care following diagnosis.
Long-Term Type 2 Diabetes Ups Pancreatic Cancer Mortality
Pre-existing T2DM of more than 5 years increases mortality risk in pancreatic adenocarcinoma.
Dietary Antioxidants Decrease Pancreatic Cancer Risk
Consuming vitamins C and E decreases risk of developing pancreatic cancer, according to UK-based researchers.
- Loading...
Loading...
Next post in Endocrine Cancer
Loading... 
Loading...